Omeros (OMER) Other Operating Expenses (2012 - 2026)

Omeros (OMER) posted Other Operating Expenses of $587000.0 for Q1 2026, down 97.8% sequentially from $26.7 million in Q4 2020.

Analysis

Omeros (OMER) Other Operating Expenses (2012 - 2026) Analysis & Trends

Omeros has reported Other Operating Expenses for 9 years, with the latest figure at $587000.0 in Q1 2026.

Quarterly Other Operating Expenses changed N/A year-over-year to $587000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $587000.0 (changed N/A YoY) and the FY2025 annual result came in at $237.6 million, changed N/A from the prior year.
Other Operating Expenses retreated to $587000.0 in Q1 2026 per OMER's latest filing, from $26.7 million in the prior quarter.
Over five years, Other Operating Expenses peaked at $587000.0 in Q1 2026 and troughed at $587000.0 in Q1 2026.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	138.77 Bn	130.92 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.51 Bn	77.52 Bn	3.93 Bn
3	Argenx Se	63.51 Bn	58.32 Bn	1.37 Bn
4	Moderna	58.20 Bn	53.06 Bn	52.00 Mn
5	Revolution Medicines	44.04 Bn	44.04 Bn	-
6	BeOne Medicines	39.99 Bn	34.89 Bn	1.53 Bn
7	Alnylam Pharmaceuticals	35.45 Bn	32.14 Bn	992.69 Mn
8	Royalty Pharma	28.40 Bn	27.56 Bn	-
9	Insmed	27.44 Bn	26.28 Bn	358.27 Mn
10	Omeros	1.37 Bn	1.37 Bn	27.73 Mn

Historic Data

Download Data